Class information for:
Level 1: OKT3//MUROMONAB CD3//ANTI OKT3 ANTIBODIES

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
10800 1034 27.8 79%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
8 4 CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL 1276458
98 3       TRANSPLANTATION//TRANSPLANTATION PROCEEDINGS//SURGERY 75394
277 2             TRANSPLANTATION//TRANSPLANTATION PROCEEDINGS//IMMUNOLOGY 19144
10800 1                   OKT3//MUROMONAB CD3//ANTI OKT3 ANTIBODIES 1034

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 OKT3 authKW 743674 6% 44% 57
2 MUROMONAB CD3 authKW 226832 1% 59% 13
3 ANTI OKT3 ANTIBODIES authKW 147649 0% 100% 5
4 OTELIXIZUMAB authKW 92277 0% 63% 5
5 OKT3 ANTIBODY authKW 88589 0% 100% 3
6 ANTI CD3 authKW 81002 1% 18% 15
7 TEPLIZUMAB authKW 78743 0% 67% 4
8 TRANSPLANTATION PROCEEDINGS journal 76992 31% 1% 322
9 TRANSPLANTATION WoSSC 69749 54% 0% 556
10 MINI YCD3 authKW 59059 0% 100% 2

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Transplantation 69749 54% 0% 556
2 Immunology 18994 64% 0% 663
3 Surgery 10751 54% 0% 560
4 Urology & Nephrology 769 9% 0% 89
5 Cardiac & Cardiovascular System 36 4% 0% 38
6 Medicine, Research & Experimental 16 3% 0% 28
7 Respiratory System 16 2% 0% 17
8 Pharmacology & Pharmacy 12 5% 0% 50
9 Hematology 8 2% 0% 18
10 Allergy 6 1% 0% 6

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 UNITE 580 52493 0% 44% 4
2 CHIM FARMACEUT PL 29530 0% 100% 1
3 ESPECIAL BIOFARM CELULA ANIM 29530 0% 100% 1
4 ESTAB FRANCAIS SANA BOURGOGNE FRANCHE COMTE 29530 0% 100% 1
5 FEDERATIF RECH NECKER ENFANTS MOLADES 29530 0% 100% 1
6 HEART TRANSPLANT POGRAM 29530 0% 100% 1
7 HUMAN ONCOL HUMAN GENET 29530 0% 100% 1
8 INSERM UMR645 29530 0% 100% 1
9 INTERNAL MEDTRANSPLANT C437 29530 0% 100% 1
10 MED NEW YORK HOSP MED ROGOSIN 29530 0% 100% 1

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 TRANSPLANTATION PROCEEDINGS 76992 31% 1% 322
2 TRANSPLANTATION 39628 15% 1% 157
3 JOURNAL OF HEART TRANSPLANTATION 22320 1% 5% 14
4 CLINICAL TRANSPLANTATION 11443 4% 1% 38
5 AMERICAN JOURNAL OF KIDNEY DISEASES 2505 3% 0% 27
6 TRANSPLANT INTERNATIONAL 944 1% 0% 10
7 CURRENT OPINION IN IMMUNOLOGY 853 1% 0% 9
8 EUROPEAN JOURNAL OF IMMUNOLOGY 781 2% 0% 19
9 JOURNAL OF IMMUNOLOGY 739 4% 0% 38
10 INTERNATIONAL YEARBOOK OF NEPHROLOGY 654 0% 2% 1

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 OKT3 743674 6% 44% 57 Search OKT3 Search OKT3
2 MUROMONAB CD3 226832 1% 59% 13 Search MUROMONAB+CD3 Search MUROMONAB+CD3
3 ANTI OKT3 ANTIBODIES 147649 0% 100% 5 Search ANTI+OKT3+ANTIBODIES Search ANTI+OKT3+ANTIBODIES
4 OTELIXIZUMAB 92277 0% 63% 5 Search OTELIXIZUMAB Search OTELIXIZUMAB
5 OKT3 ANTIBODY 88589 0% 100% 3 Search OKT3+ANTIBODY Search OKT3+ANTIBODY
6 ANTI CD3 81002 1% 18% 15 Search ANTI+CD3 Search ANTI+CD3
7 TEPLIZUMAB 78743 0% 67% 4 Search TEPLIZUMAB Search TEPLIZUMAB
8 MINI YCD3 59059 0% 100% 2 Search MINI+YCD3 Search MINI+YCD3
9 ORTHOCLONE OKT3 59059 0% 100% 2 Search ORTHOCLONE+OKT3 Search ORTHOCLONE+OKT3
10 STEROID RESISTANT REJECTION 47243 0% 40% 4 Search STEROID+RESISTANT+REJECTION Search STEROID+RESISTANT+REJECTION

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref. in
cl.		 Shr. of ref. in
cl.		 Citations
1 WILDE, MI , GOA, KL , (1996) MUROMONAB CD3 - A REAPPRAISAL OF ITS PHARMACOLOGY AND USE AS PROPHYLAXIS OF SOLID ORGAN TRANSPLANT REJECTION.DRUGS. VOL. 51. ISSUE 5. P. 865-894 122 65% 47
2 TENBERGE, RJM , PARLEVLIET, KJ , SCHELLEKENS, PTA , (1994) OKT3 TREATMENT IN CLINICAL-PRACTICE.EOS-RIVISTA DI IMMUNOLOGIA ED IMMUNOFARMACOLOGIA. VOL. 14. ISSUE 2. P. 78-84 122 72% 0
3 CHATENOUD, L , (2003) CD3-SPECIFIC ANTIBODY-INDUCED ACTIVE TOLERANCE: FROM BENCH TO BEDSIDE.NATURE REVIEWS IMMUNOLOGY. VOL. 3. ISSUE 2. P. 123-132 62 58% 171
4 DEPIS, F , HATTERER, E , BALLET, R , DAUBEUF, B , CONS, L , GLATT, S , REITH, W , KOSCO-VILBOIS, M , DEAN, Y , (2013) CHARACTERIZATION OF A SURROGATE MURINE ANTIBODY TO MODEL ANTI-HUMAN CD3 THERAPIES.MABS. VOL. 5. ISSUE 4. P. 555-564 42 64% 1
5 TODD, PA , BROGDEN, RN , (1989) MUROMONAB CD3 - A REVIEW OF ITS PHARMACOLOGY AND THERAPEUTIC POTENTIAL.DRUGS. VOL. 37. ISSUE 6. P. 871-899 67 69% 56
6 KUHN, C , WEINER, HL , (2016) THERAPEUTIC ANTI-CD3 MONOCLONAL ANTIBODIES: FROM BENCH TO BEDSIDE.IMMUNOTHERAPY. VOL. 8. ISSUE 8. P. 889 -906 51 40% 0
7 OCHI, H , ABRAHAM, M , ISHIKAWA, H , FRENKEL, D , YANG, KY , BASSO, A , WU, H , CHEN, ML , GANDHI, R , MILLER, A , ET AL (2008) NEW IMMUNOSUPPRESSIVE APPROACHES: ORAL ADMINISTRATION OF CD3-SPECIFIC ANTIBODY TO TREAT AUTOIMMUNITY.JOURNAL OF THE NEUROLOGICAL SCIENCES. VOL. 274. ISSUE 1-2. P. 9-12 37 61% 26
8 SPRANGERS, B , VAN DER SCHUEREN, B , GILLARD, P , MATHIEU, C , (2011) OTELIXIZUMAB IN THE TREATMENT OF TYPE 1 DIABETES MELLITUS.IMMUNOTHERAPY. VOL. 3. ISSUE 11. P. 1303-1316 48 44% 8
9 MALCOLM, SL , SMITH, EL , BOURNE, T , SHAW, S , (2012) A HUMANISED MOUSE MODEL OF CYTOKINE RELEASE: COMPARISON OF CD3-SPECIFIC ANTIBODY FRAGMENTS.JOURNAL OF IMMUNOLOGICAL METHODS. VOL. 384. ISSUE 1-2. P. 33-42 31 66% 4
10 TEN BERGE, IJM , PARLEVLIET, KJ , RAASVELD, MHM , BUYSMANN, S , BEMELMAN, FJ , SCHELLEKENS, PTA , (1999) GUIDELINES FOR THE OPTIMAL USE OF MUROMONAB CD3 IN TRANSPLANTATION.BIODRUGS. VOL. 11. ISSUE 4. P. 277 -284 39 74% 4

Classes with closest relation at Level 1


Rank Class id link
1 8195 BASILIXIMAB//THYMOGLOBULIN//DACLIZUMAB
2 12938 ANTI CD4 MONOCLONAL ANTIBODY//ANTI CD4//CD4 MONOCLONAL ANTIBODIES
3 20492 TRANSPLANTATION PROCEEDINGS//CD8 S6F1 LYMPHOCYTES//CELL MEDIATED CARDIOCYTE INJURY
4 9605 CD2//T11TS//CD58
5 32420 SECTM1//CD7//AGIZ DIS CENE CERRAHISI AD
6 7788 TRANSPLANTATION PROCEEDINGS//STEROID WITHDRAWAL//CORTICOSTEROID WITHDRAWAL
7 10457 ANNETTE C HAROLD C SIMMONS TRANSPLANT//LYMPHOCYTOTOXIC CROSSMATCH//IDIOPATHIC POST TRANSPLANT HEPATITIS
8 8711 JOURNAL OF HEART AND LUNG TRANSPLANTATION//HEART TRANSPLANTATION//ANTIBODY MEDIATED REJECTION
9 16097 CD3 GAMMA//CD3 EPSILON//CORE PEPTIDE
10 9947 BISPECIFIC ANTIBODY//BISPECIFIC ANTIBODIES//CATUMAXOMAB

Go to start page